Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;121(10):3020-3033.
doi: 10.1002/bit.28754. Epub 2024 Jun 4.

Using ex vivo bioengineered lungs to model pathologies and screening therapeutics: A proof-of-concept study

Mohammadali Ahmadipour  1   2   3 , Jorge Castilo Prado  3   4 , Benyamin Hakak-Zargar  2 , Malik Quasir Mahmood  2 , Ian M Rogers  3   4   5   6
Affiliations

Using ex vivo bioengineered lungs to model pathologies and screening therapeutics: A proof-of-concept study

Mohammadali Ahmadipour et al. Biotechnol Bioeng. 2024 Oct.

Abstract

Respiratory diseases, claim over eight million lives annually. However, the transition from preclinical to clinical phases in research studies is often hindered, partly due to inadequate representation of preclinical models in clinical trials. To address this, we conducted a proof-of-concept study using an ex vivo model to identify lung pathologies and to screen therapeutics in a humanized rodent model. We extracted and decellularized mouse heart-lung tissues using a detergent-based technique. The lungs were then seeded and cultured with human cell lines (BEAS-2B, A549, and Calu3) for 6-10 days, representing healthy lungs, cancerous states, and congenital pathologies, respectively. By manipulating cultural conditions and leveraging the unique characteristics of the cell lines, we successfully modeled various pathologies, including advanced-stage solid tumors and the primary phase of SARS-CoV-2 infection. Validation was conducted through histology, immunofluorescence staining, and pathology analysis. Additionally, our study involved pathological screening of the efficacy and impact of key anti-neoplastic therapeutics (Cisplatin and Wogonin) in cancer models. The results highlight the versatility and strength of the ex vivo model in representing crucial lung pathologies and screening therapeutics during the preclinical phase. This approach holds promise for bridging the gap between preclinical and clinical research, aiding in the development of effective treatments for respiratory diseases, including lung cancer.

Keywords: COVID‐19; lung cancer; lung engineering; lung regeneration; tissue engineering.

PubMed Disclaimer

References

REFERENCES

    1. Aguiar, J. A., Tremblay, B. J. M., Mansfield, M. J., Woody, O., Lobb, B., Banerjee, A., Chandiramohan, A., Tiessen, N., Cao, Q., Dvorkin‐Gheva, A., Revill, S., Miller, M. S., Carlsten, C., Organ, L., Joseph, C., John, A., Hanson, P., Austin, R. C., McManus, B. M., … Hirota, J. A. (2020). Gene expression and in situ protein profiling of candidate SARS‐CoV‐2 receptors in human airway epithelial cells and lung tissue. European Respiratory Journal, 56(3), 2001123.
    1. Ahmadipour, M., Duchesneau, P., Taniguchi, D., Waddell, T. K., & Karoubi, G. (2021). Negative pressure cell delivery augments recellularization of decellularized lungs. Tissue Engineering Part C: Methods, 27(1), 1–11.
    1. Ahmadipour, M., Taniguchi, D., Duchesneau, P., Aoki, F. G., Phillips, G., Sinderby, C., Waddell, T. K., & Karoubi, G. (2021). Use of high‐rate ventilation results in enhanced recellularization of bioengineered lung scaffolds. Tissue Engineering Part C: Methods, 27(12), 661–671.
    1. Aisner, D. L., & Marshall, C. B. (2012). Molecular pathology of non‐small cell lung cancer: A practical guide. American Journal of Clinical Pathology, 138(3), 332–346.
    1. Aldossary, S. A. (2019). Review on pharmacology of cisplatin: Clinical use, toxicity and mechanism of resistance of cisplatin. Biomedical and Pharmacology Journal, 12(1), 07–15.

LinkOut - more resources